Tag: pembrolizumab
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overa… – Press Release
In KEYNOTE-859, KEYTRUDA combined with chemotherapy also showed statistically significant improvements in progression-free survival and objective response rate, the trial's key secondary endpoints,...